Suchergebnisse - "Subramanian, Sreedhar"

PubPharm (9)

1

Ustekinumab or Vedolizumab after Failure of Anti-TNF Agents in Crohn's Disease : A Review of Comparative Effectiveness Studies

enthalten in: Journal of clinical medicine | 2024

von Sharip, M. | Nishad, N. | Pillay, L. | +3

2

Ustekinumab and Vedolizumab Are Equally Safe and Effective in Elderly Crohn's Disease Patients

enthalten in: Digestive diseases and sciences | 2023

von Gebeyehu, G. | Fiske, J. | Liu, E. | +7

3

Editorial : intravenous to subcutaneous vedolizumab-switch without glitch!

enthalten in: Alimentary pharmacology & therapeutics | 2022

von Nadesalingam, V. | Subramanian, S.

CommentOn: Aliment Pharmacol Ther. 2022 Jun;55(11):1389-1401. - PMID 35470449

4

Editorial : vedolizumab in inflammatory bowel diseases-less is more?

enthalten in: Alimentary pharmacology & therapeutics | 2021

von Townsend, T. | Subramanian, S.

CommentOn: Aliment Pharmacol Ther. 2021 Jan;53(2):265-272. - PMID 33210333

5

Letter : propensity score-handle with care. Authors' reply

enthalten in: Alimentary pharmacology & therapeutics | 2021

von Townsend, T. | Subramanian, S.

CommentOn: Aliment Pharmacol Ther. 2020 Oct;52(8):1341-1352. - PMID 32955122

6

Comparative effectiveness of ustekinumab or vedolizumab after one year in 130 patients with anti-TNF-refractory Crohn's disease

enthalten in: Alimentary pharmacology & therapeutics | 2020

von Townsend, T. | Razanskaite, V. | Dodd, S. | +14

CommentIn: Aliment Pharmacol Ther. 2021 Jan;53(2):360-361. - PMID 33368517

7

Comparative effectiveness of antitumour necrosis factor agents and vedolizumab in ulcerative colitis

enthalten in: European journal of gastroenterology & hepatology | 2019

von Davis, R. | McParland, P. | Dodd, S. | +8

8

A retrospective observational study of early experiences of vedolizumab treatment for inflammatory bowel disease in the UK : The REVIVE study

enthalten in: Medicine | 2019

von Cummings, F. | Gaya, D. | Levison, S. | +7

9

A real-world, long-term experience on effectiveness and safety of vedolizumab in adult patients with inflammatory bowel disease : The Cross Pennine study

enthalten in: Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver | 2018

von Lenti, M. | Levison, S. | Eliadou, E. | +20

1
[1]